Biotech News
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
ir.macrogenics.com2026-05-06 14:58 EST
ROCKVILLE, MD , Nov. 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser , President and CEO of MacroGenics , will participate in a